Downregulation of SPTAN1 is related to MLH1 deficiency and metastasis in colorectal cancer-Reference-Cited by-同舟云学术

Downregulation of SPTAN1 is related to MLH1 deficiency and metastasis in colorectal cancer

Published:2019-03-11 Issue:3 Volume:14 Page:e0213411
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ackermann Anne,Schrecker Christopher,Bon Dimitra,Friedrichs Nicolaus,Bankov Katrin,Wild Peter,Plotz Guido,Zeuzem Stefan,Herrmann Eva,Hansmann Martin-Leo,Brieger Angela^ORCID

Funder

Wilhelm Sander-Stiftung

Nachlässe Maria Christine Held und Erika Hecker

Institutional funds of the University Clinic Frankfurt

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. Global patterns and trends in colorectal cancer incidence and mortality;M Arnold;Gut,2016

2. Genetic alterations in colorectal cancer;T Armaghany;Gastrointest Cancer Res,2012

3. High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine;Z Gatalica;Fam Cancer,2016

4. Hereditary colorectal cancer;HT Lynch;N Engl J Med,2003

5. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma;JG Herman;Proc Natl Acad Sci U S A,1998

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer-specific alterations in nuclear matrix proteins determined by multi-omics analyses of ductal carcinoma in situ;Frontiers in Oncology;2024-08-06

2. Analysis of clinical characteristics of mismatch repair status in colorectal cancer: a multicenter retrospective study;International Journal of Colorectal Disease;2024-07-05

3. Erk Inhibition as a Promising Therapeutic Strategy for High IL-8-Secreting and Low SPTAN1-Expressing Colorectal Cancer;International Journal of Molecular Sciences;2024-05-23

4. Cancer-Specific Alterations in Nuclear Matrix Proteins Determined by Multi-omics Analyses of Ductal Carcinomain Situ;2024-02-16

5. Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico Approach;BioMedInformatics;2024-02-01